Publicacions en què col·labora amb Magí Farré Albaladejo (7)

2023

  1. Associations of hypomagnesemia in patients seeking a first treatment of alcohol use disorder

    Drug and Alcohol Dependence, Vol. 245

2022

  1. Vascular Endothelial Growth Factor as a Potential Biomarker of Neuroinflammation and Frontal Cognitive Impairment in Patients with Alcohol Use Disorder

    Biomedicines, Vol. 10, Núm. 5

2019

  1. Inflammatory mediators and dual depression: Potential biomarkers in plasma of primary and substance-induced major depression in cocaine and alcohol use disorders

    PLoS ONE, Vol. 14, Núm. 3

2018

  1. Pacientes con trastorno por uso de alcohol: resultados iniciales de un registro multicéntrico en la Red de Trastornos Adictivos-RTA. Estudio CohRTA

    Adicciones: Revista de socidrogalcohol, Vol. 30, Núm. 4, pp. 292-300

2012

  1. Unsaturated fatty alcohol derivatives of olive oil phenolic compounds with potential low-density lipoprotein (LDL) antioxidant and antiobesity properties

    Journal of Agricultural and Food Chemistry, Vol. 60, Núm. 4, pp. 1067-1074

2010

  1. Synthesis of fatty acid amides of catechol metabolites that exhibit antiobesity properties

    ChemMedChem, Vol. 5, Núm. 10, pp. 1781-1787

2005

  1. A comparative study on the acute and long-term effects of MDMA and 3,4-dihydroxymethamphetamine (HHMA) on brain monoamine levels after i.p. or striatal administration in mice

    British Journal of Pharmacology, Vol. 144, Núm. 2, pp. 231-241